The role of positron emission tomography (PET) in mediastinal staging of non-small cell lung cancer;Küçük hücreli dışı akciǧer kanserinin mediastinal evrelemesinde positron emisyon tomografisi (PET)'nin rolü

Tuberkuloz ve Toraks

Volumn 56, Issue 1, 2008, Pages 56-63

  Melek, Hüseyin ^a   Günlüoǧlu, Mehmet Zeki ^a   Demir, Adalet ^a   Akin, Hasan ^a   Medetoǧlu, Bariş ^a   Kara, Hasan Volkan ^a   Ölçmen, Aysun ^a   Dinçer, Seyyit Ibrahim ^a  

^a Yedikule teaching and research hospital of chest diseases   (Turkey)

Author keywords

Mediastinoscopy; Nsclc; Pet

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; COMPARATIVE STUDY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; MEDIASTINOSCOPY; MEDIASTINUM; MIDDLE AGED; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PREDICTION AND FORECASTING; SCINTISCANNING;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MEDIASTINOSCOPY; MEDIASTINUM; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS;

EID: 63449128771     PISSN: 04941373     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111: 1710
2. Johnston MR. Invasive staging of the mediastinum. World J Surg 1993; 17: 700
3. Goldstraw P, Mannam GC, Kaplan D, et al. Surgical management of nonsmall cell lung carcer with ipsilateral mediastinal node metastasis (N2 disease). J Thorac Cardiovasc Surg 1994; 107: 19
4. Toloza EM, Harpole L, Detterbeck F. Invasive staging of non-small cell lung cancer. A review of the current evidence. Chest 2003; 123: 157-66
5. Detterbeck FC, Jones DR, Parker LA Jr. Intrathoracic staging. In: Detterbeck FC, Rivera MP, Socinski MA, et al. (eds). Diagnosis and Treatment of Lung Cancer an Evidencebased Guide for the Practicing Clinician. Philadelphia, PA: WB Saunders, 2001: 73-93
6. Guyatt GH, Lefcoe M, Walter S, et al. Interobserver variation in the computed tomographic evaluation of mediastinal lymph node size in patients with potentially resectable lung cancer. Chest 1995; 107: 116-9
7. Staples CA, Muller NL, Miller RR, et al. Mediastinal nodes in bronchogenic carcinoma, comparison between CT and mediastinoscopy. Radiology 1988; 167: 367-72
8. Pieterman RM, van Putten JW, Meuzelaar JJ, et al. Preoperative staging of non-small-cell lung cancer with positron- emission tomography. N Engl J Med 2000; 343: 254-61
9. Dwamena BA, Sonnad SS, Angobaldo JO, et al. Metastases from non-small cell lung cancer: Mediastinal staging in the 1990s. Meta-analytic comparison of PET and CT. Radiology 1999; 213: 530-6
10. Fischer BM, Mortensen J, Hojgaard L. Positron emission tomography in the diagnosis and staging of lung cancer: a systematic, quantitative review. Lancet Oncol 2001; 2: 659-66
11. Hellwig D, Ukena D, Paulsen F, et al. Meta-analysis of the efficacy of positron emission tomography with F-18-fluorodeoxyglucose in lung tumors. Basis for discussion of the German Consensus Conference on PET in Oncology 2000 (in German). Pneumologie 2001; 55: 367-77
12. Gould MK, Kuschner WG, Rydzak CE, et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small cell lung cancer: A meta-analysis. Ann Intern Med 2003; 139: 879-92
13. Birim O, Kappetein AP, Stijnen T, et al. Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in non-small cell lung cancer. Ann Thorac Surg 2005; 79: 375-82
14. Kernstine KH, McLaughlin KA, Menda Y, et al. Can FDGPET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer? Ann Thorac Surg 2002; 73: 394-402
15. Ginsberg RJ. Evaluation of the mediastinum by invasive techniques. Surg Clin North Am 1987; 67: 1025-35
16. Gupta NC, Graeber GM, Bishop HA. Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (< 1 cm), intermediate (1 to 3 cm), and large (> 3 cm) lymph node lesions. Chest 2000; 117: 773-8
17. Sazon DA, Santiago SM, Soo Hoo GW, et al. Fluorodeoxyglucose- positron emission tomography in the detection and staging of lung cancer. Am J Respir Crit Care Med 1996; 153: 417-21
18. Gonzalez-Stawinski GV, Lemaire A, Merchant F, et al. Comparative analysis of PET and mediastinoscopy in staging NSCLC. The journal of Thoracic and Cardiovascular Surgery 2003; 126: 1900-5
19. Frank C, Detterbeck MD, Steven Falen; M. Patricia Rivera, et al. Seeking a Home for a PET, Part 2*Defining the Appropriate Place for Positron Emission Tomography Imaging in the Staging of Patients With Suspected Lung Cancer. Chest / 125 / 6 / June, 2004
20. De Leyn P, Lardinois D, Van Schi P, et al. Preoperative lymph node staging for non-small cell lung cancer. ESTS guidelines. Chest 2006
21. Lardinois D, Weder W, Hany TF, et al. Staging of nonsmall cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003; 348: 2500-7
22. Kerim Sönmezoǧlu, Akciǧer kanserlerinde FDG-PET uygulamalari{dotless}. Tüberküloz ve Toraks Dergisi 2005; 53: 94-112
23. Benjamin S, Halpern MD, Schiepers C, Wolfgang A, Weber M, et al. Presurgical Staging of Non-small Cell Lung Cancer* Positron Emission Tomography, Integrated Positron Emission Tomography/CT, and Software Image Fusion. CHEST / 128 / 4 / OCTOBER, 2005
24. De Langen AJ, Raijmakers P, Riphagen I, et al. The size of mediastinal lymph nodes and its relation with metastatic involvement: A meta-analysis. Eur J Cardiothorac Surg 2006; 29: 26-9
25. Kelly RF, Tran T, Holmstrom A, et al. Accuracy and costeffectiveness of [18F]-2-fluoro-deoxy-D-glucose-positron emission tomography scan in potentially resectable nonsmall cell lung cancer. Chest 2004; 125: 1413-23.